Summary of INHIBITEX, INC.

Quotes & Info

Enter Symbol(s):
e.g. YHOO, ^DJI

Symbol Lookup | Financial Search

INHX > SEC Filings for INHX > Form 8-K on 9-Feb-2009

All Recent SEC Filings

Show all filings for INHIBITEX, INC. | Request a Trial to NEW EDGAR Online Pro

Form 8-K for INHIBITEX, INC.

9-Feb-2009

Other Events

Item 8.01 Other Events.

On February 9, 2008, Inhibitex, Inc. issued a press release announcing that it had completed the Phase I clinical trial for FV-100 and selected lead HCV compounds for advance preclinical studies. A copy of the press release is furnished as Exhibit 99.1 to this report.

Top of the Form

Add INHX to Portfolio

Set Alert

Email to a Friend

Get SEC Filings for Another Symbol: Symbol Lookup

Quotes & Info for INHX - All Recent SEC Filings

Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now

Copyright © 2010 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.